Загрузка...
Characterization of renal biomarkers for use in clinical trials: biomarker evaluation in healthy volunteers
BACKGROUND: Several preclinical urinary biomarkers have been qualified and accepted by the health authorities (US Food and Drug Administration, European Medicines Agency, and Pharmaceuticals and Medical Devices Agency) for detecting drug-induced kidney injury during preclinical toxicologic testing....
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3928457/ https://ncbi.nlm.nih.gov/pubmed/24611000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S54956 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|